• Aurelie Leplus, Jimmy Voirin, Emmanuel Cuny, Marie Onno, Maxime Billot, Philippe Rigoard, and Denys Fontaine.
• Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Department of Neurosurgery, Fédération Hospitalo-Universitaire INOVPAIN, Nice, France; Université Côte d'Azur, Unité de Recherche Clinique Côte d'Azur, Nice, France.
• Neuromodulation. 2023 Jul 1; 26 (5): 110211081102-1108.

ObjectivesSpinal cord stimulation (SCS) is burdened with surgical complications that may require one or several surgical revision(s), challenging its risk/benefit ratio and cost-effectiveness. Our objective was to evaluate its outcome and efficacy after one or more SCS surgical revisions.Materials And MethodsWe identified and retrospectively analyzed 116 patients treated by tonic paresthesia-based SCS who experienced one or more complication(s) requiring at least one surgical revision. Data collected included initial indication, revision indication, number of revisions, and lead design (paddle or percutaneous). Outcome after SCS revision was evaluated by pain intensity decrease (comparing baseline and postrevision Numerical Rating Scale [NRS] scores) and percentage of patients reporting pain relief ≥50%. Outcome was analyzed according to the number of surgical revisions and the revision indications.ResultsMost of the patients (61%) underwent only one revision (mean delay after implantation 44 months). The most frequent causes of revisions were hardware dysfunction (32%), lead migration (23%), and infection (18%). Revision(s) repaired the SCS issue in 87% of the cases. One year after the first revision, 82% of the patients reported pain relief ≥50%, and the mean NRS decrease was 4.0 compared with baseline (p < 0.001). Benefit of SCS revision tended to decrease with the number of revisions but did not differ across revision indications. No serious surgical complications related to the revision occurred, except for three hematomas occurring after repeated revisions.ConclusionsOur data suggest that surgical revision of SCS system is safe and led to significant pain relief in most of the cases, provided that the initial indication was good and that the previous stimulation was effective. However, success of SCS revision decreases with the number of revisions.Copyright © 2023 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.

15 keywords...

hide…